NURIX THERAPEUTICS INC (NRIX) Stock Analyst Earnings Estimates
NASDAQ:NRIX - Nasdaq - US67080M1036 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 38.63M 29.85% | 76.987M 99.29% | 54.549M -29.15% | 55.512M 1.77% | 59.187M 6.62% | 88.082M 48.82% | 210.15M 138.58% | 444.42M 111.48% | 777.9M 75.04% | 1.194B 53.49% | 1.557B 30.40% | |
| EBITDA YoY % growth | -178.52M -55.10% | -141.409M 20.79% | -196.599M -39.03% | -244.344M -24.29% | -294.856M -20.67% | -420.48M -42.61% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -183.87M -55.97% | -155.063M 15.67% | -213.027M -37.38% | -272.649M -27.99% | -308.97M -13.32% | -338.734M -9.63% | -209.929M 38.03% | -14.841M 92.93% | 279.03M 1,980.13% | 666.97M 139.03% | 1.002B 50.23% | |
| Operating Margin | -475.98% | -201.41% | -390.52% | -491.15% | -522.02% | -384.57% | -99.89% | -3.34% | 35.87% | 55.86% | 64.35% | |
| EPS YoY % growth | -3.73 -36.63% | -2.65 28.95% | -2.89 -9.06% | -3.17 -9.65% | -3.29 -3.81% | -3.34 -1.60% | -1.78 46.72% | 0.48 126.92% | 3.45 620.21% | 6.80 97.05% | 9.51 39.82% |
All data in USD
| Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|
| EPS Q2Q % growth | -0.77 -1.29% | -0.78 -9.69% | -0.80 -19.79% | -0.84 -11.78% |
| Revenue Q2Q % growth | 12.721M -23.30% | 12.822M 6.04% | 13.253M 5.28% | 13.344M 0.45% |
| EBITDA Q2Q % growth | -67.422M -56.16% | -71.063M -75.20% | -74.888M -76.27% | -78.897M -63.59% |
| EBIT Q2Q % growth | -69.026M -52.65% | -70.037M -44.29% | -73.064M -33.79% | -75.926M -17.43% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2024 Q2Q % growth | -0.75 2.60% | -0.69 | -0.06 | -8.65% |
| Q3 2024 Q2Q % growth | -0.67 1.47% | -0.72 | 0.05 | 7.58% |
| Q2 2024 Q2Q % growth | -0.71 -57.78% | -0.65 | -0.06 | -9.62% |
| Q1 2024 Q2Q % growth | -0.76 -1.33% | -0.82 | 0.06 | 7.10% |
| Q4 2023 Q2Q % growth | -0.77 11.49% | -0.58 | -0.19 | -32.44% |
| Q3 2023 Q2Q % growth | -0.68 24.44% | -0.77 | 0.09 | 11.80% |
| Q2 2023 Q2Q % growth | -0.45 55.45% | -0.57 | 0.12 | 21.22% |
| Q1 2023 Q2Q % growth | -0.75 21.05% | -0.89 | 0.14 | 15.29% |
| Q4 2022 Q2Q % growth | -0.87 -2.35% | -0.80 | -0.07 | -8.12% |
| Q3 2022 Q2Q % growth | -0.90 -38.46% | -1.00 | 0.10 | 9.55% |
| Q2 2022 Q2Q % growth | -1.01 -68.33% | -1.01 | 0.00 | -0.40% |
| Q1 2022 Q2Q % growth | -0.95 -50.79% | -0.89 | -0.06 | -6.36% |
| Q4 2021 Q2Q % growth | -0.85 -66.67% | -0.71 | -0.14 | -20.12% |
| Q3 2021 Q2Q % growth | -0.65 -10.17% | -0.64 | -0.01 | -0.92% |
| Q2 2021 Q2Q % growth | -0.60 | -0.55 | -0.05 | -8.26% |
| Q1 2021 Q2Q % growth | -0.63 | -0.47 | -0.16 | -34.86% |
| Q4 2020 Q2Q % growth | -0.51 | -0.55 | 0.04 | 7.06% |
| Q3 2020 Q2Q % growth | -0.59 | -0.42 | -0.17 | -40.23% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2024 Q2Q % growth | 13.284M -12.37% | 13.116M | 168K | 1.28% |
| Q3 2024 Q2Q % growth | 12.588M -31.84% | 12.284M | 304K | 2.47% |
| Q2 2024 Q2Q % growth | 12.092M -60.58% | 22.547M | -10.455M | -46.37% |
| Q1 2024 Q2Q % growth | 16.585M 30.69% | 16.977M | -392K | -2.31% |
| Q4 2023 Q2Q % growth | 15.159M 123.58% | 22.707M | -7.548M | -33.24% |
| Q3 2023 Q2Q % growth | 18.467M 71.15% | 17.572M | 895K | 5.09% |
| Q2 2023 Q2Q % growth | 30.676M 168.38% | 26.74M | 3.936M | 14.72% |
| Q1 2023 Q2Q % growth | 12.69M 31.91% | 11.088M | 1.602M | 14.45% |
| Q4 2022 Q2Q % growth | 6.78M -8.38% | 17.515M | -10.735M | -61.29% |
| Q3 2022 Q2Q % growth | 10.79M 5.27% | 12.325M | -1.535M | -12.45% |
| Q2 2022 Q2Q % growth | 11.43M 61.21% | 10.71M | 720K | 6.72% |
| Q1 2022 Q2Q % growth | 9.62M 92.02% | 9.459M | 161K | 1.70% |
| Q4 2021 Q2Q % growth | 7.4M 10.61% | 13.459M | -6.059M | -45.02% |
| Q3 2021 Q2Q % growth | 10.25M 150.61% | 8.715M | 1.535M | 17.61% |
| Q2 2021 Q2Q % growth | 7.09M 69.62% | 8.391M | -1.301M | -15.50% |
| Q1 2021 Q2Q % growth | 5.01M 75.17% | 8.099M | -3.089M | -38.14% |
| Q4 2020 Q2Q % growth | 6.69M 259.68% | 4.024M | 2.666M | 66.25% |
| Q3 2020 Q2Q % growth | 4.09M -61.34% | 6.464M | -2.374M | -36.73% |
| Q2 2020 Q2Q % growth | 4.18M -55.72% | % | ||
| Q1 2020 Q2Q % growth | 2.86M -69.01% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -9.91% | 2.62% | -9.31% | -11.93% |
| Revenue | -18.67% | -26.1% | -2.55% | -5.94% |